• Home/
  • Browse/
  • Changes

Prescriber Bag

Advance Notices

1 April 2026

Deletion – Brand

3496B Salbutamol Cipla, LR – SALBUTAMOL, salbutamol 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules

General Pharmaceutical Benefits

Additions

Addition – Item

15220C AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL syringe (Eylea)
15221D AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL syringe (Eylea)
15248M AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL syringe (Eylea)
15260E AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL syringe (Eylea)
15128F ARIPIPRAZOLE, aripiprazole 300 mg modified release injection [1 chamber] (&) inert substance diluent [1.2 mL chamber], 1 dual chamber syringe (Abilify Maintena)
15122X ARIPIPRAZOLE, aripiprazole 400 mg modified release injection [1 chamber] (&) inert substance diluent [1.6 mL chamber], 1 dual chamber syringe (Abilify Maintena)
15243G BECLOMETASONE + FORMOTEROL + GLYCOPYRRONIUM, beclometasone dipropionate 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations (Trimbow)
15232Q BECLOMETASONE + FORMOTEROL + GLYCOPYRRONIUM, beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, 120 actuations (Trimbow)
15256Y BIMEKIZUMAB, bimekizumab 320 mg/2 mL injection, 2 mL pen devices (Bimzelx)
15262G BIMEKIZUMAB, bimekizumab 320 mg/2 mL injection, 2 mL pen devices (Bimzelx)
15233R BUDESONIDE + FORMOTEROL, budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 60 actuations (Bufomix Easyhaler 200/6)
15240D BUDESONIDE + FORMOTEROL, budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 60 actuations (Bufomix Easyhaler 200/6)
15257B DAPAGLIFLOZIN, dapagliflozin 10 mg tablet, 28 (Forxiga)
15252R EMPAGLIFLOZIN, empagliflozin 10 mg tablet, 30 (Jardiance)
15253T EMPAGLIFLOZIN, empagliflozin 10 mg tablet, 30 (Jardiance)
15270Q IVABRADINE, ivabradine 5 mg tablet, 56 (APO-Ivabradine, Coralan, IVABRADINE-WGR)
15241E IVABRADINE, ivabradine 7.5 mg tablet, 56 (APO-Ivabradine, Coralan)
15268N OPICAPONE, opicapone 50 mg capsule, 30 (Ongentys)
15236X PIOGLITAZONE, Pioglitazone 15 mg tablet, 30 (Actos)
15261F PIOGLITAZONE, Pioglitazone 15 mg tablet, 30 (Actos)
15223F PIOGLITAZONE, Pioglitazone 30 mg tablet, 30 (Actos)
15267M PIOGLITAZONE, Pioglitazone 30 mg tablet, 30 (Actos)
15222E PIOGLITAZONE, Pioglitazone 45 mg tablet, 30 (Actos)
15229M PIOGLITAZONE, Pioglitazone 45 mg tablet, 30 (Actos)
15239C PRAZIQUANTEL, praziquantel 600 mg tablet, 8 (Distocide (Korea))
15242F PROPYLENE GLYCOL, propylene glycol 0.6% eye drops, 10 mL (Systane Balance)

Addition – Brand

13495G ATOMED, DZ – ATORVASTATIN, atorvastatin 10 mg tablet, 30
8213G ATOMED, DZ – ATORVASTATIN, atorvastatin 10 mg tablet, 30
13529C ATOMED, DZ – ATORVASTATIN, atorvastatin 20 mg tablet, 30
8214H ATOMED, DZ – ATORVASTATIN, atorvastatin 20 mg tablet, 30
13468W ATOMED, DZ – ATORVASTATIN, atorvastatin 40 mg tablet, 30
8215J ATOMED, DZ – ATORVASTATIN, atorvastatin 40 mg tablet, 30
13374X ATOMED, DZ – ATORVASTATIN, atorvastatin 80 mg tablet, 30
8521L ATOMED, DZ – ATORVASTATIN, atorvastatin 80 mg tablet, 30
10800K DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% cream, 15 g
10801L DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% cream, 15 g
10802M DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% cream, 15 g
10813D DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% cream, 15 g
10824Q DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% cream, 15 g
1115Q DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% cream, 15 g
10795E DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% ointment, 15 g
10816G DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% ointment, 15 g
10820L DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% ointment, 15 g
10821M DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% ointment, 15 g
10823P DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% ointment, 15 g
1119X DIPROVANT, NB – BETAMETHASONE DIPROPIONATE, betamethasone (as dipropionate) 0.05% ointment, 15 g
5457F Stoboclo, EW – DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe
10061M Osenvelt, EW – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial
5110Y Osenvelt, EW – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial
5096F ARX-Dicloxacillin, XT – DICLOXACILLIN, dicloxacillin 250 mg capsule, 24
8121K ARX-Dicloxacillin, XT – DICLOXACILLIN, dicloxacillin 250 mg capsule, 24
10790X ARX-Dicloxacillin, XT – DICLOXACILLIN, dicloxacillin 500 mg capsule, 24
5097G ARX-Dicloxacillin, XT – DICLOXACILLIN, dicloxacillin 500 mg capsule, 24
8122L ARX-Dicloxacillin, XT – DICLOXACILLIN, dicloxacillin 500 mg capsule, 24
8558K Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 20 mg/0.2 mL injection, 10 x 0.2 mL syringes
8716R Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 20 mg/0.2 mL injection, 10 x 0.2 mL syringes
8510X Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 40 mg/0.4 mL injection, 10 x 0.4 mL syringes
8639Q Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 40 mg/0.4 mL injection, 10 x 0.4 mL syringes
8262W Enojaxect, CR – ENOXAPARIN SODIUM, enoxaparin sodium 60 mg/0.6 mL injection, 10 x 0.6 mL syringes
8640R Enojaxect, CR – ENOXAPARIN SODIUM, enoxaparin sodium 60 mg/0.6 mL injection, 10 x 0.6 mL syringes
5434B Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 80 mg/0.8 mL injection, 10 x 0.8 mL syringes
8263X Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 80 mg/0.8 mL injection, 10 x 0.8 mL syringes
5435C Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 100 mg/mL injection, 10 x 1 mL syringes
8264Y Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 100 mg/mL injection, 10 x 1 mL syringes
13688K Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 120 mg/0.8 mL injection, 10 x 0.8 mL syringes
13710N Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 120 mg/0.8 mL injection, 10 x 0.8 mL syringes
13717Y Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 150 mg/mL injection, 10 x 1 mL syringes
13729N Enoxaject, CR – ENOXAPARIN SODIUM, enoxaparin sodium 150 mg/mL injection, 10 x 1 mL syringes
11211C Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
11216H Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
11217J Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
11225T Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
13698Y Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
13707K Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
13733T Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
13751R Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
15050D Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
1963H Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
3446J Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
3449M Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9085E Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9086F Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9087G Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9088H Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9089J Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9090K Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9091L Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9431J Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
13377C Felodil XR 2.5, XT – FELODIPINE, felodipine 2.5 mg modified release tablet, 30
2361G Felodil XR 2.5, XT – FELODIPINE, felodipine 2.5 mg modified release tablet, 30
13469X ARX-FENOFIBRATE, TY – FENOFIBRATE, fenofibrate 48 mg tablet, 60
9022W ARX-FENOFIBRATE, TY – FENOFIBRATE, fenofibrate 48 mg tablet, 60
13587D ARX-FENOFIBRATE, TY – FENOFIBRATE, fenofibrate 145 mg tablet, 30
9023X ARX-FENOFIBRATE, TY – FENOFIBRATE, fenofibrate 145 mg tablet, 30

Addition – Equivalence Indicator

14594D Eylea, BN – AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial
14626T Eylea, BN – AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial
14627W Eylea, BN – AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial
14635G Eylea, BN – AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial
15199Y Praziquantel Tablets, USP 600 mg (Endo, USA), QY – PRAZIQUANTEL, Praziquantel 600 mg tablet, 6

Addition – Note

14594D AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial (Eylea)
14626T AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial (Eylea)
14627W AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial (Eylea)
14635G AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial (Eylea)
15199Y PRAZIQUANTEL, Praziquantel 600 mg tablet, 6 (Praziquantel Tablets, USP 600 mg (Endo, USA))

Deletions

Deletion – Brand

10019H Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 100 mg tablet, 30
10020J Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 100 mg tablet, 30
11260P Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 100 mg tablet, 30
13475F Tenaxil SR, RW – INDAPAMIDE, indapamide hemihydrate 1.5 mg modified release tablet, 90
8532C Tenaxil SR, RW – INDAPAMIDE, indapamide hemihydrate 1.5 mg modified release tablet, 90
13992K NOUMED LEVETIRACETAM, VO – LEVETIRACETAM, levetiracetam 250 mg tablet, 60
8654L NOUMED LEVETIRACETAM, VO – LEVETIRACETAM, levetiracetam 250 mg tablet, 60
14034P NOUMED LEVETIRACETAM, VO – LEVETIRACETAM, levetiracetam 500 mg tablet, 60
8655M NOUMED LEVETIRACETAM, VO – LEVETIRACETAM, levetiracetam 500 mg tablet, 60
13937M NOUMED LEVETIRACETAM, VO – LEVETIRACETAM, levetiracetam 1 g tablet, 60
8656N NOUMED LEVETIRACETAM, VO – LEVETIRACETAM, levetiracetam 1 g tablet, 60
10791Y Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g
10793C Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g
10812C Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g
10814E Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g
10828X Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g
1915T Momasone, AS – MOMETASONE, mometasone furoate 0.1% ointment, 15 g
10792B Momasone Alcohol Free, AS – MOMETASONE, mometasone furoate 0.1% cream, 15 g
10809X Momasone Alcohol Free, AS – MOMETASONE, mometasone furoate 0.1% cream, 15 g
10815F Momasone Alcohol Free, AS – MOMETASONE, mometasone furoate 0.1% cream, 15 g
10818J Momasone Alcohol Free, AS – MOMETASONE, mometasone furoate 0.1% cream, 15 g
10827W Momasone Alcohol Free, AS – MOMETASONE, mometasone furoate 0.1% cream, 15 g
1913Q Momasone Alcohol Free, AS – MOMETASONE, mometasone furoate 0.1% cream, 15 g

Deletion – Note

14714K OSILODROSTAT, osilodrostat 1 mg tablet, 60 (Isturisa)
14724Y OSILODROSTAT, osilodrostat 5 mg tablet, 60 (Isturisa)
14713J RISANKIZUMAB, risankizumab 150 mg/mL injection, 1 mL pen device (Skyrizi)

Deletion – Restriction

14714K OSILODROSTAT, osilodrostat 1 mg tablet, 60 (Isturisa)
14724Y OSILODROSTAT, osilodrostat 5 mg tablet, 60 (Isturisa)
14713J RISANKIZUMAB, risankizumab 150 mg/mL injection, 1 mL pen device (Skyrizi)

Alterations

Alteration – Restriction

14594D AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial (Eylea)
14627W AFLIBERCEPT, aflibercept 8 mg/0.07 mL injection, 0.07 mL vial (Eylea)
13644D BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx)
13652M BIMEKIZUMAB, bimekizumab 160 mg/mL injection, 2 x 1 mL pen devices (Bimzelx)
14792M EPCORITAMAB, Epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly)

Supply Only

Supply Only – Period Commencing

14931W DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 3 x 28 (Slinda)

Supply Only – Period Ending

1062X

BETHANECHOL, bethanechol chloride 10 mg tablet, 100 (Uro-Carb)

1948M

PROMETHAZINE, promethazine hydrochloride 50 mg/2 mL injection, 5 x 2 mL ampoules (DBL Promethazine Hydrochloride)

3374N

PROMETHAZINE, promethazine hydrochloride 50 mg/2 mL injection, 5 x 2 mL ampoules (DBL Promethazine Hydrochloride)

9479X

SILVER SULFADIAZINE, silver sulfadiazine 1% cream, 50 g (Flamazine)

Advance Notices

1 April 2026

Deletion – Brand

14722W Acarbose 100 mg tablets (Morningside, UK), DZ – ACARBOSE, acarbose 100 mg tablet, 90
14734L Acarbose 100 mg tablets (Morningside, UK), DZ – ACARBOSE, acarbose 100 mg tablet, 90
14378R Qvar 50 Autohaler, IL – BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations
8408M Qvar 50 Autohaler, IL – BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations
1302M Voltaren 100, NV – DICLOFENAC, diclofenac sodium 100 mg suppository, 20
5079H Voltaren 100, NV – DICLOFENAC, diclofenac sodium 100 mg suppository, 20
10022L Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 25 mg tablet, 30
10028T Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 25 mg tablet, 30
11263T Erlotinib APOTEX, TX – ERLOTINIB, erlotinib 25 mg tablet, 30
13442L EzSimva GH 10/20, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 20 mg tablet, 30
13595M EzSimva GH 10/80, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 80 mg tablet, 30
8882L EzSimva GH 10/80, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 80 mg tablet, 30
9484E EzSimva GH 10/20, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 20 mg tablet, 30
11107N Emend IV, MK – FOSAPREPITANT, fosaprepitant 150 mg injection, 1 vial
11245W PKU Sphere15, VF – GLYCOMACROPEPTIDE FORMULA WITH DOCOSAHEXAENOIC ACID AND LOW PHENYLALANINE, glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 30 x 27 g sachets
8729K Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule
8730L Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule
9224L Apidra, SW – INSULIN GLULISINE, insulin glulisine 100 units/mL injection, 1 x 10 mL vial
14453Q LATANOPROST-WGR, WG – LATANOPROST, latanoprost 0.005% eye drops, 2.5 mL
5552F LATANOPROST-WGR, WG – LATANOPROST, latanoprost 0.005% eye drops, 2.5 mL
8243W LATANOPROST-WGR, WG – LATANOPROST, latanoprost 0.005% eye drops, 2.5 mL
2530E Lincocin, PF – LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL vials
5144R Lincocin, PF – LINCOMYCIN, lincomycin 600 mg/2 mL injection, 5 x 2 mL vials
2481N Proladone, FF – OXYCODONE, oxycodone 30 mg suppository, 12
5194J Proladone, FF – OXYCODONE, oxycodone 30 mg suppository, 12
13371R Perindo, AF – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
13372T Perindo, AF – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
13404L Perindo, AF – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3050M Perindo, AF – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3051N Perindo, AF – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
8704D Perindo, AF – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
13476G Perindo Combi 4/1.25, AF – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30
8449Q Perindo Combi 4/1.25, AF – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30
13148B Nardil (Canada), DZ – PHENELZINE, phenelzine 15 mg tablet, 60
1897W APO-Piroxicam, TX – PIROXICAM, piroxicam 10 mg capsule, 50
1898X APO-Piroxicam, TX – PIROXICAM, piroxicam 20 mg capsule, 25
5203W APO-Piroxicam, TX – PIROXICAM, piroxicam 10 mg capsule, 50
5204X APO-Piroxicam, TX – PIROXICAM, piroxicam 20 mg capsule, 25
13927B Pro-Banthine, RW – PROPANTHELINE, propantheline bromide 15 mg tablet, 100
1953T Pro-Banthine, RW – PROPANTHELINE, propantheline bromide 15 mg tablet, 100
13982X Norprolac, FP – QUINAGOLIDE, quinagolide 75 microgram tablet, 30
8822H Norprolac, FP – QUINAGOLIDE, quinagolide 75 microgram tablet, 30
2000G Salbutamol Cipla, LR – SALBUTAMOL, salbutamol 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules
1109J Artane, RW – TRIHEXYPHENIDYL, trihexyphenidyl (benzhexol) hydrochloride 2 mg tablet, 200
1110K Artane, RW – TRIHEXYPHENIDYL, trihexyphenidyl (benzhexol) hydrochloride 5 mg tablet, 200

1 May 2026

Deletion – Brand

8594H AMISULPRIDE-WGR, WG – AMISULPRIDE, amisulpride 100 mg tablet, 30
10414D Eliquis, BQ – APIXABAN, apixaban 5 mg tablet, 28
13469X Fenofibrate Cipla, LR – FENOFIBRATE, fenofibrate 48 mg tablet, 60
9022W Fenofibrate Cipla, LR – FENOFIBRATE, fenofibrate 48 mg tablet, 60
14458Y RASAGILINE-WGR, WG – RASAGILINE, rasagiline 1 mg tablet, 30
1952R RASAGILINE-WGR, WG – RASAGILINE, rasagiline 1 mg tablet, 30
2285G NOUMED TERBINAFINE, VO – TERBINAFINE, terbinafine 250 mg tablet, 42
2804N NOUMED TERBINAFINE, VO – TERBINAFINE, terbinafine 250 mg tablet, 42

1 June 2026

Deletion – Brand

14408H Chemists' Own Macrogol with Electrolytes, RW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets
8612G Chemists' Own Macrogol with Electrolytes, RW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets

Palliative Care

Advance Notices

1 June 2026

Deletion – Brand

5389P Chemists' Own Macrogol with Electrolytes, RW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets

Highly Specialised Drugs Program (Private Hospital)

Additions

Addition – Item

15234T RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15235W RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15263H RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15254W RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15259D RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15264J RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)

Addition – Brand

13332Q Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
9615C Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes

Alterations

Alteration – Restriction

11472T NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
12176W NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
13064N NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
13111C NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
14096X NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
12610Q RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi)
13647G RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi)
14647X RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi)

Advance Notices

1 April 2026

Deletion – Brand

10386P Pomalyst, BQ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
10417G Pomalyst, BQ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
12661J Pomalyst, BQ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14
12668R Pomalyst, BQ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14

1 May 2026

Deletion – Brand

12146G Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60
6430K Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60

Highly Specialised Drugs Program (Public Hospital)

Additions

Addition – Item

15244H RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15245J RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15255X RAVULIZUMAB, ravulizumab 300 mg/3 mL injection, 3 mL vial (Ultomiris)
15225H RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15246K RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)
15258C RAVULIZUMAB, ravulizumab 1.1 g/11 mL injection, 11 mL vial (Ultomiris)

Addition – Brand

13308K Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes
5733R Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes

Alterations

Alteration – Restriction

11363C NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
12177X NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
12972R NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
13052Y NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
13083N NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
14099C NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza)
12614X RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi)
13655Q RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi)
14659M RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi)

Advance Notices

1 April 2026

Deletion – Brand

10387Q Pomalyst, BQ – POMALIDOMIDE, pomalidomide 4 mg capsule, 21
10406Q Pomalyst, BQ – POMALIDOMIDE, pomalidomide 3 mg capsule, 21
12665N Pomalyst, BQ – POMALIDOMIDE, pomalidomide 4 mg capsule, 14
12666P Pomalyst, BQ – POMALIDOMIDE, pomalidomide 3 mg capsule, 14

1 May 2026

Deletion – Brand

12149K Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60
5619R Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60

Highly Specialised Drugs Program (Community Access)

Additions

Addition – Item

15231P TENOFOVIR DISOPROXIL + EMTRICITABINE + EFAVIRENZ, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablet 600 mg/200 mg/300 mg (Camber, USA))

Addition – Equivalence Indicator

11732L Tenofovir Disoproxil Emtricitabine Efavirenz Viatris 300/200/600, AL – TENOFOVIR DISOPROXIL + EMTRICITABINE + EFAVIRENZ, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30

Addition – Note

11732L TENOFOVIR DISOPROXIL + EMTRICITABINE + EFAVIRENZ, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 (Tenofovir Disoproxil Emtricitabine Efavirenz Viatris 300/200/600)

Botulinum Toxin Program

Additions

Addition – Item

15226J INCOBOTULINUMTOXINA, incobotulinumtoxinA 100 units injection, 1 vial (Xeomin)
15247L INCOBOTULINUMTOXINA, incobotulinumtoxinA 100 units injection, 1 vial (Xeomin)
 

Efficient Funding of Chemotherapy (Private Hospital)

Additions

Addition – Item

15269P GLOFITAMAB,
Glofitamab 2.5 mg/2.5 mL injection, 2.5 mL vial (Columvi)
15227K GLOFITAMAB,
Glofitamab 10 mg/10 mL injection, 10 mL vial (Columvi)
15266L GLOFITAMAB,
Glofitamab 10 mg/10 mL injection, 10 mL vial (Columvi)
15237Y IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)
15224G NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
15251Q OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)

Addition – Brand

12219D BORTRACZO, JM – BORTEZOMIB, bortezomib 2.5 mg/mL injection, 1 mL vial
12219D BORTRACZO, JM – BORTEZOMIB, bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial

Addition – Note

2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)

Deletions

Deletion – Item

14736N BLINATUMOMAB,
blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto)
11644W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12304N IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12601F IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
10748Q NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
10775D NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11143L NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11152Y NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11157F NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11159H NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11425H NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11434T NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11532Y NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11626X NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11627Y NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
12315E NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
12574T NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
13117J NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
14860D NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
14872R NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Deletion – Caution

2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)

Alterations

Alteration – Restriction

2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)

Alteration – Maximum Quantity

From To
2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy) 		360 80

Alteration – Number of Repeats

From To
2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy) 		3 1

Efficient Funding of Chemotherapy (Public Hospital)

Additions

Addition – Item

15250P GLOFITAMAB,
Glofitamab 2.5 mg/2.5 mL injection, 2.5 mL vial (Columvi)
15228L GLOFITAMAB,
Glofitamab 10 mg/10 mL injection, 10 mL vial (Columvi)
15249N GLOFITAMAB,
Glofitamab 10 mg/10 mL injection, 10 mL vial (Columvi)
15230N IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)
15238B NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
15265K OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)

Addition – Brand

12227M BORTRACZO, JM – BORTEZOMIB, bortezomib 2.5 mg/mL injection, 1 mL vial
12227M BORTRACZO, JM – BORTEZOMIB, bortezomib 3.5 mg/1.4 mL injection, 1.4 mL vial

Deletions

Deletion – Item

14718P BLINATUMOMAB,
blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto)
11628B IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12322M IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12583G IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
10745M NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
10764M NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11150W NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11153B NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11158G NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11160J NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11411N NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11435W NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11543M NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11636K NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11642R NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
12323N NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
12602G NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
13121N NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
14855W NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
14859C NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Deletion – Caution

2641B IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)

Alterations

Alteration – Restriction

2641B IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)

Alteration – Maximum Quantity

From To
2641B IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy) 		360 80

Alteration – Number of Repeats

From To
2641B IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy) 		3 1

Related Pharmaceutical Benefits for Public Hospital use

Alterations

Alteration – Restriction

14803D EPCORITAMAB, Epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly)

Advance Notices

1 April 2026

Deletion – Brand

11103J Emend IV, MK – FOSAPREPITANT, fosaprepitant 150 mg injection, 1 vial
5899L Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule